Skip to main content
. Author manuscript; available in PMC: 2016 May 13.
Published in final edited form as: Am J Hematol. 2014 Aug 27;89(11):E212–E217. doi: 10.1002/ajh.23819

Table 1.

Pain and ACS Rates for time on and off Hydroxyurea in the SAC cohort.#

Type of Event On Off P-value*
Hydroxyurea Hydroxyurea
Pain rate (events/patient year) 1.02 (2.41) § 0.56 (0.99) 0.003
ACS rate (events/patient year) 0.18 (0.71) 0.25 (0.40) 0.891
*

Wilcoxon signed rank test

#

Includes only those followed since birth and administered hydroxyurea; n=52

§

Median (IQR)

Duration of hydroxyurea therapy ranges from 0.10 to 13.92 years. The mean is 3.59 years, median is 2.50 years.